Narayana Hrudayalaya

1,396.80
-7.75
(-0.55%)
Market Cap
28,703.50 Cr
EPS
38.86
PE Ratio
36.61
Dividend Yield
0.28 %
52 Week High
1,419.90
52 Week low
1,080.00
PB Ratio
8.95
Debt to Equity
0.50
Sector
Hospitals
Add Ratio

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Analyst Rating
- By Refinitiv from9 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy77.78 %
77.78 %
Hold0.0 %
0.0 %
Sell22.22 %
22.22 %

Company News

View All News
Caret
positive
Narayana Hrudayalaya Initiates 1,100-bed Hospital Project in KolkataToday
Narayana Hrudayalaya has laid the foundation stone for a new 1,100-bed hospital project called 'Narayana Health City' in Kolkata. The company plans to invest approximately ₹900 crore in the first phase of this project.
positive
Narayana Hrudayalaya Initiates 1,100-Bed Hospital Project in Kolkata1 day ago
Narayana Hrudayalaya has laid the foundation stone for a new 1,100-bed hospital project called 'Narayana Health City' in Kolkata. The company plans to invest approximately ₹900 crore in the first phase of the project.
positive
Narayana Hrudayalaya Confirms Q3 FY25 Financial Results and Expansion Plans2 days ago
Narayana Hrudayalaya has issued a clarification regarding recent news articles discussing their Q3 FY25 financial results. The company confirmed a 2.6% increase in net profit to Rs. 192.9 crores and plans for capacity expansion with a focus on oncology. The company stated that the news items published in mainstream media are based on their disclosed financial results.
View more
Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
1,010.25 1,00,309.40 94.60 5,584.10 18.77 1,058 -17.46 41.32
6,317.55 91,892.10 70.18 19,165.50 14.74 917 49.14 33.93
619.35 46,044.90 58.33 6,931.20 8.99 645 89.49 46.36
1,235.55 32,402.40 63.86 2,759.20 25.09 326 15.71 68.44
1,396.80 28,703.50 36.61 5,093.40 10.96 790 2.66 58.76
535.45 21,687.50 62.32 2,511.20 12.94 336 20.76 28.70
414.95 20,844.70 79.62 3,723.70 22.85 205 -69.22 29.16
1,322.95 13,197.10 55.49 1,334.00 10.76 218 10.06 40.97
1,490.40 9,768.40 50.79 1,095.50 21.32 177 20.14 42.36
499.75 7,074.70 127.73 1,929.10 12.97 41 129.41 48.64
Growth Rate
Revenue Growth
10.96 %
Net Income Growth
30.17 %
Cash Flow Change
-1.66 %
ROE
-3.76 %
ROCE
-15.58 %
EBITDA Margin (Avg.)
7.25 %

Quarterly Financial Results

Quarterly Financials
Mar 2015
Jun 2015
Sept 2015
Dec 2015
Mar 2016
Jun 2016
Sept 2016
Dec 2016
Mar 2017
Jun 2017
Sept 2017
Dec 2017
Mar 2018
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Revenue
365
378
409
400
432
455
492
459
489
526
565
558
653
655
714
735
776
782
829
791
750
398
611
755
846
867
952
967
951
1,041
1,173
1,140
1,236
1,249
1,324
1,222
1,303
1,364
1,424
1,385
Expenses
326
344
360
358
392
402
426
406
425
473
502
502
597
607
640
657
676
675
702
684
659
486
575
648
698
728
774
787
768
842
898
874
946
963
997
925
985
1,037
1,092
1,060
EBITDA
39
34
49
42
40
54
66
53
64
53
63
56
56
49
74
79
101
107
127
107
92
-87
36
107
148
139
179
180
182
200
275
266
290
286
327
297
318
327
332
325
Operating Profit %
10 %
8 %
11 %
10 %
8 %
11 %
13 %
11 %
12 %
9 %
10 %
9 %
8 %
7 %
10 %
10 %
12 %
13 %
15 %
13 %
11 %
-23 %
4 %
14 %
17 %
15 %
18 %
18 %
18 %
19 %
21 %
23 %
23 %
22 %
24 %
23 %
23 %
23 %
22 %
22 %
Depreciation
19
18
18
19
21
19
20
20
21
22
29
24
26
33
34
35
36
41
43
46
55
46
46
47
45
45
46
46
47
48
49
57
56
59
55
63
65
62
65
70
Interest
12
9
8
6
6
6
5
6
6
10
8
8
21
17
18
18
18
22
22
21
21
20
19
19
18
17
17
16
16
15
15
19
21
21
23
25
28
34
35
37
Profit Before Tax
10
10
26
20
13
29
41
28
37
21
26
24
9
-1
22
26
47
43
62
40
16
-153
-30
42
85
77
116
117
119
137
211
190
214
206
248
209
226
232
232
219
Tax
11
11
16
14
8
12
15
11
15
10
10
10
-1
3
8
13
10
13
17
9
4
-34
-26
1
17
1
17
20
50
27
42
36
40
22
22
21
35
30
33
26
Net Profit
-1
-1
10
6
5
17
27
17
22
11
17
14
10
-4
14
13
37
30
45
31
12
-120
-3
41
68
76
99
98
69
111
169
154
173
184
227
188
191
202
199
193
EPS in ₹
0.00
-0.03
0.52
0.29
0.25
0.85
1.31
0.84
1.10
0.54
0.82
0.70
0.48
-0.21
0.67
0.63
1.83
1.49
2.23
1.55
0.59
-5.90
-0.17
2.01
3.35
3.75
4.89
4.80
3.40
5.45
8.31
7.57
8.53
9.06
11.16
9.26
9.39
9.92
9.78
9.50

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
1,370
1,556
1,647
2,536
2,637
2,891
2,770
3,131
4,162
5,625
Fixed Assets
913
1,055
1,082
1,848
1,838
2,092
1,961
1,980
2,336
2,651
Current Assets
260
286
302
479
527
586
665
909
1,294
1,946
Capital Work in Progress
20
14
53
35
56
12
20
67
259
514
Investments
0
87
96
9
17
86
120
132
252
844
Other Assets
437
401
416
644
725
701
669
951
1,315
1,615
Total Liabilities
1,370
1,556
1,647
2,536
2,637
2,891
2,770
3,131
4,162
5,625
Current Liabilities
343
315
323
510
510
602
703
780
987
1,110
Non Current Liabilities
258
365
361
989
1,045
1,153
946
861
1,042
1,629
Total Equity
769
876
963
1,036
1,082
1,137
1,121
1,489
2,132
2,885
Reserve & Surplus
568
674
761
833
878
933
917
1,286
1,928
2,681
Share Capital
200
204
204
204
204
204
204
204
204
204

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
-6
42
28
-22
89
8
-2
59
-4
97
Investing Activities
-223
-150
-146
-520
-162
-189
-113
-267
-1,176
-1,458
Operating Activities
77
174
219
182
279
443
304
485
1,085
1,067
Financing Activities
140
18
-45
315
-27
-247
-194
-159
88
489

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Promoter
63.85 %
63.85 %
63.85 %
63.85 %
63.85 %
63.85 %
63.85 %
63.85 %
63.85 %
63.85 %
63.85 %
63.85 %
63.85 %
63.85 %
63.85 %
63.85 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
11.60 %
0.00 %
10.91 %
10.01 %
9.68 %
9.44 %
DIIs
14.80 %
15.55 %
16.15 %
14.61 %
13.76 %
13.43 %
16.18 %
14.58 %
14.14 %
11.95 %
10.89 %
9.46 %
9.51 %
8.23 %
7.90 %
8.69 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.01 %
0.01 %
0.00 %
0.00 %
Public / Retail
4.64 %
4.97 %
4.85 %
5.11 %
5.92 %
6.87 %
5.86 %
6.93 %
7.10 %
7.99 %
8.46 %
9.04 %
10.00 %
11.68 %
12.13 %
11.58 %
Others
16.71 %
15.63 %
15.14 %
16.43 %
16.46 %
15.85 %
14.11 %
14.64 %
14.90 %
16.20 %
5.20 %
17.65 %
5.73 %
6.23 %
6.43 %
6.43 %
No of Share Holders
0
36,360
44,526
43,565
43,807
52,747
65,173
68,130
75,370
86,631
1,02,994
1,20,506
1,38,052
1,60,686
1,78,356
1,77,792

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.00 0.00 0.00 1 1 0.00 1 2.5 4 0.00
Dividend Yield (%) 0.00 0.00 0.00 0.4 0.25 0.00 0.13 0.19 0.28 0.00

Corporate Action

Announcements

Intimation Under Regulation 30 Read With Para B Of Part A Of Schedule III Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.
1 day ago
Rumour verification - Regulation 30(11)
3 days ago
Announcement under Regulation 30 (LODR)-Allotment
3 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
3 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
4 days ago
Announcement under Regulation 30 (LODR)-Newspaper Publication
4 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
6 days ago
Intimation Of Acquisition Of Shares By A Wholly-Owned Overseas Subsidiary Of The Company
7 days ago
Integrated Filing (Financial)
7 days ago
Announcement under Regulation 30 (LODR)-Investor Presentation
7 days ago
Announcement under Regulation 30 (LODR)-Press Release / Media Release
7 days ago
Board Meeting Outcome for Outcome Of Board Meeting Held On February 14 2025
7 days ago
Result_Unaudited Financial Result For The Quarter And Nine Month Ended December 31 2024
7 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Feb 07, 2025, 15:02
Board Meeting Intimation for To Consider And Approve The Unaudited Standalone And Consolidated Financial Results For The Quarter Ended December 31 2024
Feb 07, 2025, 14:34
Intimation Regarding Purchase Of Land At Bengaluru
Feb 05, 2025, 17:18
Announcement under Regulation 30 (LODR)-Issue of Securities
Jan 29, 2025, 16:42
Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements
Jan 27, 2025, 23:02
Announcement under Regulation 30 (LODR)-Credit Rating
Jan 24, 2025, 19:34
Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot
Jan 13, 2025, 16:49
Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
Jan 13, 2025, 16:44
Report On Investor Complaints
Jan 09, 2025, 16:49
Intimation Of Grant Of Insurer Certificate Permitting Cayman Integrated Healthcare Ltd. Foreign Step-Down Subsidiary Company To Offer Health Insurance To Residents Of The Cayman Islands
Dec 28, 2024, 13:29

Technical Indicators

RSI(14)
Neutral
60.37
ATR(14)
Volatile
49.64
STOCH(9,6)
Neutral
55.54
STOCH RSI(14)
Neutral
65.88
MACD(12,26)
Bullish
3.02
ADX(14)
Weak Trend
17.59
UO(9)
Bearish
56.39
ROC(12)
Uptrend But Slowing Down
3.57
WillR(14)
Overbought
-19.72